Screening of Silent Myocardial Ischemia in Type 2 Diabetic Patients | Zendy

Sophie Jacqueminet | Zendy; Olivier Barthélémy | Zendy; Claude Le Feuvre | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Screening of Silent Myocardial Ischemia in Type 2 Diabetic Patients

Author(s) -

Sophie Jacqueminet,

Olivier Barthélémy,

Claude Le Feuvre

Publication year - 2010

Publication title -

diabetes care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.636

H-Index - 363

eISSN - 1935-5548

pISSN - 0149-5992

DOI - 10.2337/dc09-2248

Subject(s) - medicine , asymptomatic , coronary artery disease , cardiology , thallium , diabetes mellitus , stress testing (software) , ischemia , type 2 diabetes , stress echocardiography , diabetic cardiomyopathy , type 2 diabetes mellitus , heart failure , cardiomyopathy , endocrinology , inorganic chemistry , chemistry , computer science , programming language

The prevalence of silent myocardial ischemia (SMI) is more frequent in diabetic patients and is associated with a worse prognosis (1). In order to prevent adverse cardiac events, current guidelines recommend detection of asymptomatic coronary artery disease (CAD) in type 2 diabetic patients with high cardiovascular (CV) risk (2,3). The ECG stress test is recommended but frequently inconclusive in type 2 diabetic patients.This study aimed to compare stress thallium-201 single photon emission computed tomography (SPECT) with dobutamine echocardiography (DE) for the screening of SMI and CAD in type 2 diabetic patients.The study was designed with 55 and 30% anticipated rates of positive SPECT and DE, …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research